{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:58Z","timestamp":1785560278865,"version":"3.56.0"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2169\/internalmedicine.6310-25","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T22:08:30Z","timestamp":1767305310000},"page":"2068-2077","source":"Crossref","is-referenced-by-count":0,"title":["Real-world Diagnosis and Testing of Acquired Hemophilia A in Japan: A Web-based Physician Survey"],"prefix":"10.2169","volume":"65","author":[{"given":"Yoshinobu","family":"Seki","sequence":"first","affiliation":[{"name":"Department of Hematology, Niigata University Medical and Dental Hospital, Japan"},{"name":"Department of Hematology, Niigata Cancer Center Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Go","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ieko","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Sapporo University of Health Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 9: 331-354, 1996.","DOI":"10.1016\/S0950-3536(96)80067-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 124: 86-90, 2004.","DOI":"10.1046\/j.1365-2141.2003.04731.x"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Collins PW, Hirsch S, Baglin TP, et al.; UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 109: 1870-1877, 2007.","DOI":"10.1182\/blood-2006-06-029850"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Knoebl P, Marco P, Baudo F, et al.; the EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 10: 622-631, 2012.","DOI":"10.1111\/j.1538-7836.2012.04654.x"},{"key":"5","unstructured":"5. Japan Foundation for AIDS Prevention [Japanese]. The Ministry of Health, Labour and Welfare of Japan. Nationwide survey on blood coagulation disorders [Internet]. 2022 [cited 2025 May 14]. Available from: https:\/\/api-net.jfap.or.jp\/image\/data\/blood\/r04_research\/r04_research.pdf"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Webert KE. Acquired hemophilia A. Semin Thromb Hemost 38: 735-741, 2012.","DOI":"10.1055\/s-0032-1326779"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coppola A, Favaloro EJ, Tufano A, Di Minno MND, Cerbone AM, Franchini M. Acquired inhibitors of coagulation factors: part I - acquired hemophilia A. Semin Thromb Hemost 38: 433-446, 2012.","DOI":"10.1055\/s-0032-1315757"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shima M, Tanaka I, Kawai Y, Tsuji H, Nakamura S, Morita T. A survey of acquired inhibitors of blood coagulation in Japan. Jpn J Thromb Haemost 14: 107-121, 2003.","DOI":"10.2491\/jjsth.14.107"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tanaka I, Amano K, Taki M, Oka T, Sakai M, Shirahata A. A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan - analysis of prognostic factors. Jpn J Thromb Hemost 19: 140-153, 2008.","DOI":"10.2491\/jjsth.19.140"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121: 21-35, 2003.","DOI":"10.1046\/j.1365-2141.2003.04162.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kruse-Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 92: 695-705, 2017.","DOI":"10.1002\/ajh.24777"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Tiede A, Collins P, Knoebl P, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica 105: 1791-1801, 2020.","DOI":"10.3324\/haematol.2019.230771"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sakai M, Amano K, Ogawa K, et al. Guidelines for the management of acquired hemophilia A: 2017 revision. Nihon Kessen Shiketsu Gakkaishi (Jpn J Thromb Hemost) 28: 715-747, 2017.","DOI":"10.2491\/jjsth.28.715"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Franchini M, Vaglio S, Marano G, et al. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology 22: 514-520, 2017.","DOI":"10.1080\/10245332.2017.1319115"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sakurai Y, Takeda T. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res 2014: 320674, 2014.","DOI":"10.1155\/2014\/320674"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Collins P, Baudo F, Huth-K\u00fchne A, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes 3: 161, 2010.","DOI":"10.1186\/1756-0500-3-161"},{"key":"17","unstructured":"17. Ministry of Health, Labour and Welfare. Ethical guidelines for medical and health research involving human subjects. (in Japanese) [Internet]. 2023 [cited 2025 May 14]. Available from: https:\/\/www.mhlw.go.jp\/content\/001077424.pdf"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kessler CM, Kn\u00f6bl P. Acquired haemophilia: an overview for clinical practice. Eur J Haematol 95: 36-44, 2015.","DOI":"10.1111\/ejh.12689"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Dolan G, Benson G, Bowyer A, et al. Principles of care for acquired hemophilia. Eur J Haematol 106: 762-773, 2021.","DOI":"10.1111\/ejh.13592"},{"key":"20","unstructured":"20. SRL. Coagulation- and fibrinolysis-related test [Internet]. [cited 2025 May 14]. Available from: https:\/\/test-directory-en.srl.info\/akiruno_en\/test\/list\/21"},{"key":"21","unstructured":"21. Asakura H, Kako M, Morishita E, et al. Thrombosis and Hemostasis Directly Linked to Clinical Practice. Revised 3rd ed. Chugai Igakusha, Tokyo, 2024: 41-45. (in Japanese)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ieko M, Ohmura K, Naito S, et al. Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant. Explor Immunol 3: 286-299, 2023.","DOI":"10.37349\/ei.2023.00103"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Takeyama M, Sasai K, Matsumoto T, et al. Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan. Int J Hematol 115: 163-172, 2022.","DOI":"10.1007\/s12185-021-03249-w"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Osaki T, Souri M, Ogawa Y, Sato H, Mitsui T, Ichinose A. Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: a single-center analysis. Thromb Res 213: 154-162, 2022.","DOI":"10.1016\/j.thromres.2022.03.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ieko M, Yoshida M, Naito S, Ohmura K, Takahashi N. Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan. Int J Hematol 110: 197-204, 2019.","DOI":"10.1007\/s12185-019-02674-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 18: 2828-2839, 2020.","DOI":"10.1111\/jth.15047"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Bowyer A, Kitchen S, Makris M. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies. Int J Lab Hematol 33: 154-158, 2011.","DOI":"10.1111\/j.1751-553X.2010.01261.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6310-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:58Z","timestamp":1785557638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6310-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6310-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"6310-25"}}